S&P 500   2,999.26 (+1.12%)
DOW   27,043.36 (+0.96%)
QQQ   193.48 (+1.25%)
AAPL   235.84 (-0.01%)
FB   189.70 (+3.50%)
MSFT   141.41 (+1.33%)
GOOGL   1,241.80 (+1.97%)
AMZN   1,759.68 (+1.34%)
NVDA   198.57 (+6.45%)
MU   46.37 (+3.37%)
BABA   176.43 (+3.08%)
GE   8.87 (+1.60%)
TSLA   258.55 (+0.62%)
T   37.91 (+1.17%)
ACB   3.79 (+7.98%)
NFLX   285.00 (-0.19%)
BAC   29.87 (+2.51%)
GILD   65.55 (+1.61%)
DIS   130.30 (+0.45%)
S&P 500   2,999.26 (+1.12%)
DOW   27,043.36 (+0.96%)
QQQ   193.48 (+1.25%)
AAPL   235.84 (-0.01%)
FB   189.70 (+3.50%)
MSFT   141.41 (+1.33%)
GOOGL   1,241.80 (+1.97%)
AMZN   1,759.68 (+1.34%)
NVDA   198.57 (+6.45%)
MU   46.37 (+3.37%)
BABA   176.43 (+3.08%)
GE   8.87 (+1.60%)
TSLA   258.55 (+0.62%)
T   37.91 (+1.17%)
ACB   3.79 (+7.98%)
NFLX   285.00 (-0.19%)
BAC   29.87 (+2.51%)
GILD   65.55 (+1.61%)
DIS   130.30 (+0.45%)
Log in

Pure Bioscience Stock Price, News & Analysis (OTCMKTS:PURE)

$0.25
-0.01 (-3.85 %)
(As of 10/15/2019 12:14 PM ET)
Today's Range
$0.24
Now: $0.25
$0.25
50-Day Range
$0.26
MA: $0.29
$0.31
52-Week Range
$0.25
Now: $0.25
$0.64
Volume16,187 shs
Average Volume16,778 shs
Market Capitalization$19.25 million
P/E RatioN/A
Dividend YieldN/A
Beta0.03
PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. It manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection and formulates with other compounds. Read More…

Industry, Sector and Symbol

Industry Miscellaneous chemical products
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:PURE
CUSIPN/A
Phone619-596-8600

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.77 million
Book Value$0.02 per share

Profitability

Net Income$-7,440,000.00
Net Margins-394.40%

Miscellaneous

Employees9
Market Cap$19.25 million
Next Earnings Date10/24/2019 (Estimated)
OptionableNot Optionable

Receive PURE News and Ratings via Email

Sign-up to receive the latest news and ratings for PURE and its competitors with MarketBeat's FREE daily newsletter.


Pure Bioscience (OTCMKTS:PURE) Frequently Asked Questions

What is Pure Bioscience's stock symbol?

Pure Bioscience trades on the OTCMKTS under the ticker symbol "PURE."

How were Pure Bioscience's earnings last quarter?

Pure Bioscience, Inc. (OTCMKTS:PURE) posted its earnings results on Wednesday, June, 13th. The company reported ($0.02) EPS for the quarter, meeting analysts' consensus estimates of ($0.02). The business had revenue of $0.39 million for the quarter, compared to the consensus estimate of $1 million. Pure Bioscience had a negative net margin of 394.40% and a negative return on equity of 515.22%. View Pure Bioscience's Earnings History.

When is Pure Bioscience's next earnings date?

Pure Bioscience is scheduled to release their next quarterly earnings announcement on Thursday, October 24th 2019. View Earnings Estimates for Pure Bioscience.

Has Pure Bioscience been receiving favorable news coverage?

News stories about PURE stock have been trending somewhat positive on Tuesday, according to InfoTrie Sentiment. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Pure Bioscience earned a daily sentiment score of 1.4 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Pure Bioscience.

Who are some of Pure Bioscience's key competitors?

What other stocks do shareholders of Pure Bioscience own?

Who are Pure Bioscience's key executives?

Pure Bioscience's management team includes the folowing people:
  • Mr. Henry R. Lambert, CEO, Sec. & Director (Age 68)
  • Mr. Mark Stuart Elliott, VP of Fin. (Age 44)
  • Mr. Thomas Richard Myers, Chief Operating Officer (Age 67)
  • Ms. Bridget C. Tinsley-Cormier M.S., Sr. VP of Technology & Bus. Devel. and VP of Market Devel.

How do I buy shares of Pure Bioscience?

Shares of PURE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Pure Bioscience's stock price today?

One share of PURE stock can currently be purchased for approximately $0.25.

How big of a company is Pure Bioscience?

Pure Bioscience has a market capitalization of $19.25 million and generates $1.77 million in revenue each year. Pure Bioscience employs 9 workers across the globe.View Additional Information About Pure Bioscience.

What is Pure Bioscience's official website?

The official website for Pure Bioscience is http://www.purebio.com/.

How can I contact Pure Bioscience?

Pure Bioscience's mailing address is 1725 GILLESPIE WAY, EL CAJON CA, 92020. The company can be reached via phone at 619-596-8600.


MarketBeat Community Rating for Pure Bioscience (OTCMKTS PURE)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  88 (Vote Outperform)
Underperform Votes:  83 (Vote Underperform)
Total Votes:  171
MarketBeat's community ratings are surveys of what our community members think about Pure Bioscience and other stocks. Vote "Outperform" if you believe PURE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PURE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel